Here are what the editors at HealthDay consider to be the most important developments in Urology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Study Supports PSA Screening for Male BRCA2 Carriers
WEDNESDAY, Nov. 27, 2019 (HealthDay News) -- Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of the BRCA2 mutation, which is associated with a higher incidence of prostate cancer, younger age at diagnosis, and clinically significant tumors, according to the interim results of a study published in the December issue of European Urology.
U.S. Life Expectancy Dropped Since 2014 for Working-Age Adults
TUESDAY, Nov. 26, 2019 (HealthDay News) -- U.S. life expectancy increased from 1959 to 2016 but has been decreasing since 2014, according to research published in the Nov. 26 issue of the Journal of the American Medical Association.
Many Cancer Patients Interested in Pathology Consultations
TUESDAY, Nov. 26, 2019 (HealthDay News) -- When surveyed, a majority of cancer patients expressed interest in participating in a patient-pathologist consultation program, according to a study recently published in the Archives of Pathology & Laboratory Medicine.
Cancer Patients With Obesity Show Poorer Psychosocial Health
TUESDAY, Nov. 26, 2019 (HealthDay News) -- Patients with breast or prostate cancer who are obese score higher in psychosocial problem-related distress than nonobese patients, according to a study recently published in Psycho-Oncology.
Racial Differences Found in Gene Panels for Prostate Cancer Prognosis
MONDAY, Nov. 25, 2019 (HealthDay News) -- For three commercial panels for prostate cancer prognosis, gene expression differs for European-American men (EAM) and African-American men (AAM), according to a study published online Nov. 22 in Cancer Epidemiology, Biomarkers & Prevention.
Electronic Health Record Usability Graded F by Physicians
FRIDAY, Nov. 22, 2019 (HealthDay News) -- The usability of current electronic health records (EHRs) is classified as unacceptable, with physician-rated EHR usability independently linked to the odds of burnout, according to a study published online Nov. 14 in the Mayo Clinic Proceedings.
Employee Premiums, Deductibles Eating Larger Share of Income
THURSDAY, Nov. 21, 2019 (HealthDay News) -- During the last decade, health care costs have eaten up a larger share of income for millions of middle-class Americans with employer coverage, according to Trends in Employer Health Care Coverage, 2008-2018, a Nov. 21 report from The Commonwealth Fund.
More Appropriate Prostate Cancer Tx Seen at Multidisciplinary Clinic
WEDNESDAY, Nov. 20, 2019 (HealthDay News) -- Receiving care at a multidisciplinary (MultiD) clinic facilitates adherence to evidence-based national treatment guidelines for prostate cancer, according to a study published online Nov. 19 in Cancer.
White House Wants Hospitals, Insurers to Provide Actual Costs of Care
MONDAY, Nov. 18, 2019 (HealthDay News) -- New rules requiring hospitals and insurers to disclose the actual prices for common tests and procedures before they are performed have been proposed by the Trump Administration.
Bipartisan Bill to Curb Drug Costs Backed by White House
MONDAY, Nov. 18, 2019 (HealthDay News) -- A bipartisan Senate bill that would curb prescription drug costs is being backed by the Trump administration as a new poll shows that many Americans think the White House has done little to tackle the issue.
Revision, Removal Risks Low for Synthetic Midurethral Slings
MONDAY, Nov. 18, 2019 (HealthDay News) -- The long-term risk for women with stress urinary incontinence needing surgical revision or removal after initial placement of synthetic midurethral slings is low, according to a study published in the November issue of Obstetrics & Gynecology.
Survey of U.S. Registered Nurses Points to Worsening Shortages
THURSDAY, Nov. 14, 2019 (HealthDay News) -- The 2019 AMN Healthcare Survey of Registered Nurses raises concerns about the outlook for the nursing profession in the United States.
Imaging Rates Continue to Rise Despite Efforts to Reduce
WEDNESDAY, Nov. 13, 2019 (HealthDay News) -- Despite initiatives to reduce the use of medical imaging, rates continue to rise in both the United States and Ontario, Canada, according to a study recently published in the Journal of the American Medical Association.
Testosterone Therapy Tied to Increase in Short-Term VTE Risk
TUESDAY, Nov. 12, 2019 (HealthDay News) -- For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism (VTE), according to a study published online Nov. 11 in JAMA Internal Medicine.
PSA Levels No Different With Exposure to Antidiabetes Meds
THURSDAY, Nov. 7, 2019 (HealthDay News) -- Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to a study published online Nov. 6 in JAMA Network Open.
Medical Practices Burdened by Regulatory Requirements
TUESDAY, Nov. 5, 2019 (HealthDay News) -- The vast majority of group medical practices report that regulatory requirements, including prior authorization and quality payment programs, are burdensome, according to a survey released by the Medical Group Management Association.
Dietary Patterns May Possibly Be Linked to Prostate Cancer Risk
TUESDAY, Nov. 5, 2019 (HealthDay News) -- Plant-based diets are associated with a decreased or unchanged risk for prostate cancer, while animal-based diets, especially those containing dairy products, are associated with an increased or unchanged risk, according to a review published in the November issue of the Journal of the American Osteopathic Association.
Seriously Ill Medicare Beneficiaries Face Financial Hardship
MONDAY, Nov. 4, 2019 (HealthDay News) -- Seriously ill Medicare enrollees experience considerable financial distress, according to a report published in the November issue of Health Affairs.
Dr. Stephen Hahn Nominated to Head FDA
MONDAY, Nov. 4, 2019 (HealthDay News) -- Radiation oncology expert Stephen Hahn, M.D., has been nominated as the new U.S. Food and Drug Administration commissioner.
Recommendations Developed to Address Clinician Burnout
FRIDAY, Nov. 1, 2019 (HealthDay News) -- In Taking Action Against Clinician Burnout, a new report published online Oct. 23 by the National Academies of Sciences, Engineering, and Medicine, recommendations are presented to address clinician burnout.